Clinical Stage Of Localized Prostate Cancer Of No Prognostic Significance In Predicting Biochemical Recurrence Risk After Radical Prostatectomy

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Cancer / Oncology
Article Date: 11 Jun 2008 - 2:00 PDT

email to a friend   printer friendly   opinions  

ORLANDO, FL (UroToday.com) - Data is emerging that clinical staging is no longer predictive of outcomes in men with localized prostate cancer, as PSA screening becomes more and more prevalent.

Reese and colleagues used the CaPSURE database to evaluate the impact of clinical staging on disease progression following radical retropubic prostatectomy. 3,635 men were included in the study, and a multivariate analysis revealed that clinical stage is indeed no longer a significant factor in predicting disease recurrence in men with localized CaP.

Presented by Adam C Reese, MD, Matthew R Cooperberg, MD, Christopher J Kane, MD, Peter R Carroll, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor Alexander Kutikov, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

• Additional
• References
• Citations